Platelet activation by oxidized low density lipoprotein is mediated by Cd36 and scavenger receptor-A

被引:92
作者
Korporaal, Suzanne J. A.
Van Eck, Miranda
Adelmeijer, Jelle
Ijsseldijk, Martin
Out, Ruud
Lisman, Ton
Lenting, Peter J.
Van Berkel, Theo J. C.
Akkerman, Jan-Willem N.
机构
[1] Univ Utrecht, Med Ctr, Dept Clin Chem & Haematol G03 550, NL-3508 GA Utrecht, Netherlands
[2] Univ Utrecht, Inst Biomembranes, NL-3508 TC Utrecht, Netherlands
[3] Leiden Univ, Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands
关键词
platelets; LDL; oxidized LDL; CD36; scavenger receptor-A;
D O I
10.1161/ATVBAHA.107.150698
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective-The interaction of platelets with low density lipoprotein (LDL) contributes to the development of cardiovascular disease. Platelets are activated by native LDL (nLDL) through apoE Receptor 2' (apoER2')-mediated signaling to p38(MAPK) and by oxidized LDL (oxLDL) through lysophosphatidic acid (LPA) signaling to Rho A and Ca2+. Here we report a new mechanism for platelet activation by oxLDL. Methods and Results-Oxidation of nLDL increases p38MAPK activation through a mechanism that is (1) independent of LPA, and (2) unlike nLDL-signaling not desensitized by prolonged platelet-LDL contact or inhibited by receptorassociated protein or chondroitinase ABC. Antibodies against scavenger receptors CD36 and SR-A alone fail to block p38MAPK activation by oxLDL but combined blockade inhibits p38MAPK by > 40% and platelet adhesion to fibrinogen under flow by > 60%. Mouse platelets deficient in either CD36 or SR-A show normal p38MAPK activation by oxLDL but combined deficiency of CD36 and SR-A disrupts oxLDL-induced activation of p38MAPK by > 70%. Conclusion-These findings reveal a novel platelet-activating pathway stimulated by oxLDL that is initiated by the combined action of CD36 and SR-A.
引用
收藏
页码:2476 / 2483
页数:8
相关论文
共 37 条
[1]
PLATELET ACTIVATION BY OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS [J].
ARDLIE, NG ;
SELLEY, ML ;
SIMONS, LA .
ATHEROSCLEROSIS, 1989, 76 (2-3) :117-124
[2]
Identification of the principal proteoglycan-binding site in LDL -: A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding [J].
Borén, J ;
Olin, K ;
Lee, I ;
Chait, A ;
Wight, TN ;
Innerarity, TL .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) :2658-2664
[3]
Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets - Relevance of the effect of oxidized LDL on platelet function [J].
Chen, LY ;
Mehta, P ;
Mehta, JL .
CIRCULATION, 1996, 93 (09) :1740-1746
[4]
Activation-dependent surface expression of LOX-1 in human platelets [J].
Chen, MY ;
Kakutani, M ;
Naruko, T ;
Ueda, M ;
Narumiya, S ;
Masaki, T ;
Sawamura, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (01) :153-158
[5]
How the protease thrombin talks to cells [J].
Coughlin, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11023-11027
[6]
PLATELET-ADHESION TO FIBRIN(OGEN) [J].
ENDENBURG, SC ;
HANTGAN, RR ;
SIXMA, JJ ;
DEGROOT, PG ;
ZWAGINGA, JJ .
BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (01) :139-142
[7]
THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[8]
ESTERBAUER H, 1987, J LIPID RES, V28, P495
[9]
Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence [J].
Greaves, DR ;
Gough, PJ ;
Gordon, S .
CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (05) :425-432
[10]
Early platelet activation by low density lipoprotein via p38MAP kinase [J].
Hackeng, CM ;
Relou, IAM ;
Pladet, MW ;
Gorter, G ;
van Rijn, HJM ;
Akkerman, JWN .
THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) :1749-1756